Paloma Partners’s Avanos Medical AVNS Stock Holding History

Paloma Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,479	Closed	-$326K	–	1883
2021 Q3	$326K	Buy	10,479 +241	+2%	+$8.18K	0.01%	689
2021 Q2	$371K	Sell	10,238 -1,230	-11%	-$50.9K	0.01%	1182
2021 Q1	$502K	Buy	+11,468	New	+$538K	0.01%	1120
2020 Q4	–	Sell	-9,146	Closed	-$304K	–	1642
2020 Q3	$304K	Buy	+9,146	New	+$292K	0.01%	1471
2019 Q4	–	Sell	-12,879	Closed	-$482K	–	2139
2019 Q3	$482K	Buy	12,879 +6,726	+109%	+$257K	0.01%	1192
2019 Q2	$268K	Buy	+6,153	New	+$263K	﹤0.01%	1363
2018 Q1	–	Sell	-8,199	Closed	-$379K	–	1930
2017 Q4	$379K	Buy	+8,199	New	+$377K	0.01%	1442
2017 Q3	–	Sell	-5,200	Closed	-$204K	–	2086
2017 Q2	$204K	Sell	5,200 -52,256	-91%	-$1.97M	﹤0.01%	1985
2017 Q1	$2.19M	Buy	57,456 +41,946	+270%	+$1.63M	0.03%	728
2016 Q4	$573K	Sell	15,510 -8,457	-35%	-$302K	0.01%	1455
2016 Q3	$830K	Buy	+23,967	New	+$839K	0.01%	1146
2015 Q2	–	Sell	-10,764	Closed	-$530K	–	1776
2015 Q1	$530K	Buy	+10,764	New	+$499K	0.02%	756

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Paloma Partners's AVNS Position: Q4 2021 in Review

Paloma Partners sold out of Avanos Medical (AVNS) in Q4 2021, closing a stake of 10,479 shares — an estimated $326K sold.

Paloma Partners first reported a position in AVNS in Q1 2015 and held it in 12 quarters. The position peaked at $2.19M in Q1 2017. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

Paloma Partners reported no remaining Avanos Medical position as of Q4 2021 after selling out during the quarter.
Paloma Partners sold 10,479 Avanos Medical shares in Q4 2021, an estimated $326K.
Paloma Partners first reported a position in Avanos Medical in Q1 2015 and held it in 12 quarters.
Paloma Partners's Avanos Medical position peaked at $2.19M in Q1 2017.
297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on Paloma Partners's 13F filing for Q4 2021, filed 14 Feb 2022.